AVITA Medical Inc RCEL
News
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
Avita Lands Government Contract Worth Up to $25.5 Million to Supply RECELL Products

